Feedback Systems and Methods to Enhance Obstructive and Other Obesity Treatments, Optionally Using Multiple Sensors

• US 20120116182A1
• Filed: 09/30/2011
• Published: 05/10/2012
• Est. Priority Date: 09/23/2004
• Status: Active Grant

• Current Assignee: IntraPace, Inc.
• Original Assignee: IntraPace, Inc.
• Inventors: Wong, Ken, Potosky, John C., Province, Rose, Brynelsen, Charles R., Imran, Mir
• Granted Patent: US 8,934,976 B2
• Time in Patent Office: Days
• US Class Current: 600/301
• CPC Class Codes: A61F 2005/002 for sensing mechanical parameters
• CPC Class Codes: A61F 2005/0023 for sensing chemical parameters
• CPC Class Codes: A61F 5/0026 Anti-eating devices using electrical stimulation
• CPC Class Codes: A61F 5/003 inflatable
• CPC Class Codes: A61F 5/0036 Intragastrical devices
• CPC Class Codes: A61F 5/005 Gastric bands
• CPC Class Codes: A61F 5/0056 using injection ports
• CPC Class Codes: A61F 5/0059 with wireless means
• CPC Class Codes: A61F 5/0069 in the wall of the stomach

Abstract

Feedback systems and methods enhance obstructive and other obesity treatments by presenting feedback regarding patients'"'"' actual eating. An ingestion restricting implant body can be deployed along the gastrointestinal tract. In some embodiments, ingestion alters the implant body, which, in turn, generates signals. The generated signals can be used to inhibit unhealthy ingestion by the patient. In other embodiments, the implant body can be altered by signals so as to selectable change the restriction imposed on the gastrointestinal tract, optionally in response to ingestion events, an eating schedule, or the like. The implant body may comprise a gastric band. Sensor signals may be processed to identify ingestion and/or characterize ingestion material, and the results may be displayed on a screen for a patient or coach to view.

Claims

1. A therapeutic implant system for treating a patient, the patient having a gastrointestinal tract and an unhealthy ingestion pattern, the therapeutic implant system comprising:

an ingestion restricting implant body deployable along the gastrointestinal tract so as to separate the gastrointestinal tract into a restricted portion of the gastrointestinal tract and an gastric pouch portion of the gastrointestinal tract upstream of the restricted portion, the implant body comprising a gastric band defining a channel therethrough, the gastrointestinal tract extendable through the channel of the implant body, wherein the gastric band comprises a fluid-filled pressure bladder disposed between the channel and a support structure such that changes in a fluid pressure within the fluid pressure bladder correspond with changes in an engagement force between the gastrointestinal tract and the gastric band;

a sensor coupleable to the gastric pouch portion of the gastrointestinal pouch so that signals are generated in response to transient changes in the gastric pouch and the signals indicate an ingestion event; and

a processor coupled to the signal generator and the implant body such that, in response to the signals, the unhealthy ingestion pattern by the patient is inhibited in use sufficiently to modify the unhealthy ingestion pattern toward a healthier ingestion pattern.

2. The system of claim 1, further comprising at least one of:

a display coupled to the processor, the display showing eating events identified in response to the signals during a plurality of days and configured for communicating to the patient or a lifestyle coach;

an actuator coupled to the processor so as to alter the fluid pressure within the bladder in response to the ingestion event; and

at least two electrodes coupled to the processor so as to stimulate tissue of the gastrointestinal tract in response to the ingestion event.

3. The system of claim 2, further comprising at least one of a pressure sensor, a temperature sensor, an optical sensor, an impedance sensor, a pH sensor, or an acoustic sensor coupled to the processor.

4. The system of claim 3, wherein the optical sensor comprises a color sensor.

5. The system of claim 1, wherein command signals are transmitted to the bladder from the processor, and wherein the altering of the engagement force is induced by an actuator in response to the sensor signals so that the pressure within the bladder is decreased each day to allow healthy ingestion and increased each day to inhibit unhealthy ingestion.

6. The system of claim 5, further wherein energizing the actuator activates the gastric band so as to increase restriction and decrease ingestion into the patient.

7. The system of claim 5, wherein energizing the actuator deactivates the gastric band so as to decrease restriction and allow increased ingestion into the patient.

8. The system of claim 1, wherein the sensor is included in a transgastric probe having a probe body having a transgastric wall traversing portion, the sensor separated along the probe body from the wall traversing portion so as to be disposed within an interior of the transgastric pouch.

9. The system of claim 8, wherein the transgastric probe includes two or more members selected from the group consisting of a temperature sensor, an electrode, and a color detector.

10. The system of claim 1, further comprising at least two electrodes coupled to the processor so as to deliver electrical stimulation to at least one internal organ of the living body.

11. The system of claim 10, further comprising two sensors coupled to the processor and used to generate the signals, and wherein the processor is configured to process the signals to as to identify transient changes in the gastric pouch portion of the gastrointestinal tract.

12. The system of claim 1, further comprising a temperature sensor coupled to the processor so as to provide a temperature from within the gastric pouch portion of the gastrointestinal tract.

13. The system of claim 1, further comprising a sensor coupled to the processor, wherein the sensor comprises a color sensor.

14. A system for treating a patient, the patient having a gastrointestinal tract, the system comprising:

an ingestion restricting implant body deployable along the gastrointestinal tract;

at least two sensors so as to transmit signals in response to ingestion into the patient in use; and

a processor coupled to the at least two sensors, the processor, in response to the signals, generating output comprising at least one member selected from the group consisting of;

ingestion display signals, and

patient treatment signals.

15. A therapeutic implant system for treating a patient, the patient having a gastrointestinal tract and an unhealthy ingestion pattern, the therapeutic implant system comprising:

an ingestion restricting implant body implantable along the gastrointestinal tract so as to separate the gastrointestinal tract into a restricted portion of the gastrointestinal tract and an gastric pouch portion of the gastrointestinal tract upstream of the restricted portion;

a sensor configured to engage the gastric pouch portion; and

a processor coupleable to the sensor so as to transmit signals therebetween, wherein the signals are transmitted in correlation with transient changes in the gastric pouch potion of the gastrointestinal tract in use.

16. The therapeutic implant of claim 15, wherein the implant body has a first configuration and a second configuration, the size, compliance, or shape of the implant body in the second configuration being different than the size, compliance, or shape of the implant body in the first configuration such that the implant body has an enhanced inhibition of ingestion in the second configuration.

17. A therapeutic implant for treating a patient, the patient having a gastrointestinal tract and an unhealthy ingestion pattern, the therapeutic implant comprising:

an ingestion restricting implant body implantable along the gastrointestinal tract;

at least two sensors for generating signals; and

a processor coupled to the at least two sensors and the implant body so as to transmit the signals therebetween, wherein the signals are transmitted in correlation with an ingestion event.

18. A method for treating a patient, the patient having a gastrointestinal tract, the method comprising:

deploying at least a portion of an implant along the gastrointestinal tract, the implant having a body, at least three sensors and a processor;

identifying, during a day and in response to signals sent from the sensors to the processor, a candidate characterization of an ingested material;

determining whether the ingested material constitutes an allowed ingestion in response to the candidate characterization, and if so, allowing the ingested material to traverse the body of the implant along the gastrointestinal tract;

determining whether the ingested material constitutes an unhealthy ingestion in response to the candidate characterization, and if so, transmitting signals from the processor to the body so as to alter a shape, compliance, and/or size of the body such that the body restricts the unhealthy ingestion.

19. A transgastric probe comprising:

a probe body having a transgastric wall traversing portion and a gastric cavity portion, the gastric wall traversing portion configured for extending through a gastric wall of a gastrointestinal tract of a patient so as to support the gastric cavity portion within a gastric cavity; and

a plurality of sensors mounted to the probe body, at least one of the sensors disposed along the gastric cavity portion of the probe body so as to be disposed within an interior of the gastric cavity when the probe body is implanted, wherein the sensors include two or more members selected from the group consisting of a temperature sensor, an electrode, and a color detector.